Saturday, July 11, 2026

Drug profile · INN

bc006

bc006 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — bc006
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

bc006 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN bc006

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. BC006 Phase 1 · Chinese Academy of · Advanced Solid Tumors (Including GCTTS)
  2. aspirin 100mg/d therapy Approved · First People's Hospital · Coronary Atherosclerosis

Frequently asked questions

What is bc006?

bc006 is an FDA-listed pharmaceutical active ingredient.